Nasway Use as an Independent Adverse Prognostic Factor in Oral Squamous Cell Carcinoma: A Retrospective Cohort Study from Uzbekistan. (2026). Journal of Carcinogenesis, 25(1), 671-679. https://doi.org/10.66838/J.Carcinog.25.1.671-679